Cronos Group Inc. (CRON) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cronos Group Inc. (CRON:NASDAQ), powered by AI.

Current Price
$2.60
P/E Ratio
-105.5
Market Cap
997M
Sector
Healthcare
What is the Cronos Group Inc. stock price forecast?

Cronos Group Inc. is currently trading at $2.60. View real-time AI analysis on Alpha Lenz.

What is Cronos Group Inc. insider trading activity?

View the latest insider trading data for Cronos Group Inc. on Alpha Lenz.

What is Cronos Group Inc.'s P/E ratio?

Cronos Group Inc.'s P/E ratio is -105.5.

Cronos Group Inc.

NASDAQ · CRON
$2.60-0.03(-1.14%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Cronos Group Inc.'s future dividend policy...
Alpha Chat Insight

Cronos Group Inc. trades at a P/E of -105.5 (undervalued) with modest ROE of -0.9%. 3Y revenue CAGR of 19.1% highlights clear growth momentum.

Ask for details

Company Overview

Cronos Group Inc. is a vertically integrated cannabis company that engages in the cultivation, manufacturing, and distribution of cannabis and related products. Its primary focus is on producing and selling cannabis flower, oils, and derivative products for recreational and medicinal purposes. The company's operations span across different international markets, leveraging strategic partnerships to expand its footprint and influence in the rapidly evolving cannabis industry. Cronos Group is known for investing in research and development to advance cannabinoid innovation and enhance its product offerings. It not only addresses consumer needs through various brands but also aims to comply with stringent regulatory frameworks in the regions it serves. As an active participant in the cannabis sector, Cronos Group plays a crucial role in shaping industry standards and responding to changing market dynamics. With an emphasis on sustainability and corporate responsibility, Cronos contributes to the broader acceptance and understanding of cannabis as a major component of the health and wellness market.

CEOMr. Michael Ryan Gorenstein J.D.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees459

Company Statistics

FY 2025

Profile

$997.02MMarket Cap
$146.59MRevenue
0.00Shares Out
459Employees

Margins

42.81%Gross
21.88%EBITDA
-13.30%Operating
-11.68%Pre-Tax
-2.00%Net

Valuation

-105.54P/E
0.91P/B
6.80EV/Sales
7.97EV/EBITDA
-5247.46P/FCF

Growth (CAGR)

19.11%Rev 3Yr
25.70%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.25%ROA
-0.88%ROE
-1.65%ROIC

Financial Health

$791.79MCash & Cash Equivalents
$-737.61MNet Debt
4.74%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Cronos Group Inc. (ticker: CRON) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 459 employees. Market cap is $997M.

The current price is $2.6 with a P/E ratio of -105.54x and P/B of 0.91x.

ROE is -0.88% and operating margin is -13.30%. Annual revenue is $147M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Cronos Group Inc. (CRON) Stock Forecast 2026 $2.60 — Price, Financials & Analyst Targets | Alpha Lenz